Zhejiang Pushkang Biotechnology Co., Ltd.
PrivateLast Round
Private Equity
Mar 25, 2024
Total Funding Raised
$117.94M
Company Overview
Zhejiang Pushkang Biotechnology Co., Ltd. is a biotechnology company that specializes in the research, development, and production of in-vitro diagnostic (IVD) products, including point-of-care testing (POCT) solutions for coagulation, biochemistry, and molecular diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zhejiang Pushkang Biotechnology Co., Ltd. Comparables
Compare Zhejiang Pushkang Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tianjin MNCHIP Technologies Co., Ltd. | 86% | |
| Chengdu Seamaty Technology Co., Ltd. | 86% | |
| Micropoint Biotechnologies | 84% |
Zhejiang Pushkang Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Mar 25, 2024 | ||||
| Series C Extension | Oct 24, 2022 | ||||
| Series C | Feb 22, 2021 | ||||
| Series B Extension | Jan 1, 2021 | ||||
| Series B | Apr 1, 2020 | ||||
Series A Extension | Dec 1, 2019 |
Zhejiang Pushkang Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Changan Huitong Group | Series C Extension |
| Power Capital | Private Equity |
| YuanBio Venture Capital | Series B Extension, Series B |
| 健壹资本 | Series B |
| Shanghai Shiyue Asset Management | Private Equity, Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors grew 34% MoM, reaching 2.1K.
- Nov 8, 2025
Monthly visitors grew 971% MoM, reaching 2.3K.
Zhejiang Pushkang Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Zhejiang Pushkang Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Zhejiang Pushkang Biotechnology Co., Ltd. a public or private company?
Zhejiang Pushkang Biotechnology Co., Ltd. is a private company.
What is the current stock price of Zhejiang Pushkang Biotechnology Co., Ltd.?
Zhejiang Pushkang Biotechnology Co., Ltd. is a private company with no public stock price. Caplight tracks Zhejiang Pushkang Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Zhejiang Pushkang Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Zhejiang Pushkang Biotechnology Co., Ltd. is not publicly available.
Can I buy Zhejiang Pushkang Biotechnology Co., Ltd. stock?
Zhejiang Pushkang Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Zhejiang Pushkang Biotechnology Co., Ltd.'s last funding round?
Zhejiang Pushkang Biotechnology Co., Ltd.'s most recent funding round was Private Equity on March 25, 2024.
Who are the main investors in Zhejiang Pushkang Biotechnology Co., Ltd.?
Key investors in Zhejiang Pushkang Biotechnology Co., Ltd. include YuanBio Venture Capital, Shanghai Shiyue Asset Management.
Will Zhejiang Pushkang Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Zhejiang Pushkang Biotechnology Co., Ltd..
How can I track Zhejiang Pushkang Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zhejiang Pushkang Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.